The specification of Balversa produced by Lucius is 3mg * 28pills, and the current price is $111.
Balversa, as a novel oral anticancer drug, has shown significant efficacy in the treatment of urothelial carcinoma.
Balversa is a small molecule inhibitor of fibroblast growth factor receptor (FGF···【more】
Release date:2024-11-13Recommended:162
Balversa, a new targeted anti-cancer drug, provides new treatment hope for patie···【more】
Release date:2024-08-26Recommended:113
Balversa is a novel targeted anti-cancer drug that inhibits the FGFR signaling p···【more】
Release date:2024-08-26Recommended:91
Balversais an oral, targeted anti-cancer drug that specifically inhibits the FGF···【more】
Release date:2024-08-26Recommended:106